What articles discuss the anesthetic management of donor hepatectomy from an anesthetist's perspective?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Anesthetic Management of Donor Hepatectomy: Key Articles and Evidence

For anesthesiologists managing donor hepatectomy, the 2023 ERAS Society Guidelines for Liver Surgery 1 provide the most comprehensive and current evidence-based framework, with specific recommendations for multimodal analgesia over routine thoracic epidural analgesia in open procedures, and minimal regional techniques for laparoscopic approaches.

Essential Guideline Resources

Primary Guideline: ERAS Society 2022 Recommendations (2023)

The most authoritative source is the 2023 ERAS Society Guidelines 1, which specifically addresses anesthetic management for liver surgery including donor hepatectomy. This guideline provides strong evidence-based recommendations on:

Analgesia Strategy for Open Donor Hepatectomy:

  • Multimodal analgesia is strongly recommended over routine thoracic epidural analgesia (TEA) 1
  • While TEA provides excellent pain control, it carries significant disadvantages including hypotension requiring vasopressors, risk of acute kidney injury, and problematic timing of catheter removal due to postoperative coagulopathy
  • For open living donor hepatectomy specifically, ketorolac infusion combined with IV fentanyl PCA improved analgesia and reduced opioid requirements in an RCT of 60 patients 1
  • Intrathecal opiates combined with multimodal analgesia provide similar results to TEA but with lower likelihood of postoperative hypotension and reduced length of stay 1

Analgesia for Laparoscopic Donor Hepatectomy:

  • Regional anesthesia techniques are unnecessary 1
  • Multimodal analgesia combined with judicious IV opiates provides functional analgesia
  • Smaller incisions and earlier gut function enable rapid transition to oral analgesia

Alternative Regional Techniques:

  • Continuous wound infiltration (CWI) catheters show similar static pain scores to TEA but shorter length of stay 1
  • TAP blocks combined with CWI provide equivalent outcomes to TEA 1

Complementary Guidelines for Cirrhotic Patients

The 2025 EASL Guidelines on Extrahepatic Abdominal Surgery in Cirrhosis 2 provide critical insights applicable to donor hepatectomy, particularly regarding:

Anesthetic Drug Selection:

  • Fentanyl is the safest opioid - no toxic metabolites, minimal dosage adjustment needed 2
  • Avoid long-acting opioids like morphine due to delayed elimination 2
  • Tramadol can be used cautiously at lower doses (≤400 mg/day) 2
  • Volatile anesthetics (isoflurane, sevoflurane, desflurane) are weakly recommended over propofol for maintenance 2
  • Atracurium and cisatracurium are suitable neuromuscular blockers as they don't rely on hepatic excretion 2

Regional Anesthesia Cautions:

  • Epidural catheter placement should be avoided in patients with significant hepatic dysfunction (CTP B or C) due to epidural hematoma risk 2
  • Benefits must be carefully weighed against risks 2

Fluid Management:

  • Maintain low central venous pressure during hepatic transection to reduce blood loss 2
  • Use trans-esophageal echocardiography for volume assessment rather than CVP monitoring 2
  • Avoid hydroxyethyl starch (HES) 130/0.4 due to acute kidney injury risk 2
  • Balanced electrolyte solutions preferred over 0.9% saline 2

Contemporary Research Articles

Recent High-Quality Studies

Perioperative Management Overview (2026): The article by Gastroenterology Clinics of North America 3 provides a comprehensive review of perioperative management for living liver donors, covering donor selection, surgical technique, anesthetic management, and Enhanced Recovery After Surgery protocols with emphasis on quality of life outcomes.

Laparoscopic Donor Hepatectomy Experience (2023): Turkish single-center experience 4 emphasizes that effective communication and teamwork between surgeons and anesthesiologists are the most critical factors for donor safety. This study of 8 laparoscopic cases (6 right lobe, 2 left lobe) demonstrated mean blood loss of 437 ± 294 mL with operation time of 593 ± 94 minutes.

Evolution from Open to Laparoscopic Technique (2022): This study 5 documents the anesthetic evolution showing:

  • Laryngeal mask airway replaced intubation in 50% of laparoscopic cases
  • Erector spinae plane blocks used in 25% of cases
  • Lung-protective ventilation with low tidal volume and PEEP applied
  • Decreased crystalloid infusion and no central venous catheterization needed
  • No intraoperative transfusions required
  • Reduced hospital length of stay

National Survey on Pain Management (2025): A comprehensive US survey of 37 centers 6 revealed:

  • 78.4% have protocolized perioperative pain management
  • 83.8% have protocolized postoperative pain management
  • Acetaminophen is the most common postoperative analgesic (75.7% for right lobe, 80% for left lobe)
  • TAP blocks are the most frequently used regional technique (43.2% for right lobe, 48% for left lobe)
  • Epidural catheters used more in left lobe (40%) than right lobe (32.4%) donors
  • Significant variation exists between centers in pain management strategies

Critical Anesthetic Considerations

Specific to Donor Safety

Acetaminophen Dosing:

  • Safe after major hepatectomy if liver function preserved 1
  • Reduce dose to 2 g/day if significant parenchyma resected 1

NSAID Use:

  • Only use postoperatively if renal function is normal 1
  • Avoid due to risk of renal impairment, hepatorenal syndrome, and GI hemorrhage in compromised patients 2

PONV Prophylaxis:

  • Use multimodal approach with 2 antiemetic drugs 7
  • 5HT3 antagonists are first-line therapy 7
  • Low-dose dexamethasone improves liver regeneration but use cautiously in diabetics 7

Monitoring Considerations

  • Bispectral index monitoring helps guide anesthetic depth 2
  • Trans-esophageal echocardiography is safe and effective for hemodynamic assessment 2
  • Maintain mean arterial pressure >65 mmHg to preserve hepatic perfusion 2
  • Monitor neuromuscular blockade 2

Common Pitfalls to Avoid

  1. Routine use of TEA in open donor hepatectomy - while providing excellent analgesia, the risks (hypotension, AKI, coagulopathy complications) outweigh benefits in the ERAS era 1, 7

  2. Excessive fluid administration - maintain low CVP during parenchymal transection to minimize blood loss, but balance against tissue perfusion needs 2

  3. Using long-acting opioids - morphine elimination is delayed; fentanyl is safer 2

  4. Placing epidurals in patients with coagulopathy risk - avoid in CTP B/C or when significant postoperative coagulopathy anticipated 2

  5. Full-dose acetaminophen after major resection - reduce to 2 g/day when significant liver tissue removed 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.